{"url":"https://lda.senate.gov/api/v1/filings/94661b32-e0a8-4512-b65d-5abb577b975c/","filing_uuid":"94661b32-e0a8-4512-b65d-5abb577b975c","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2017,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/94661b32-e0a8-4512-b65d-5abb577b975c/print/","filing_document_content_type":"text/html","income":"140000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Eugenia Pierson","dt_posted":"2017-07-19T22:35:28.547000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 Massachusetts Ave. NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":4301,"url":"https://lda.senate.gov/api/v1/registrants/4301/","house_registrant_id":31381,"name":"ARNOLD & PORTER KAYE SCHOLER LLP","description":"Law firm","address_1":"601 Massachusetts Ave. NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NICHOLAS TOWNSEND","contact_telephone":"+1 202-942-5249","dt_updated":"2026-07-30T11:53:37.108571-04:00"},"client":{"id":104656,"url":"https://lda.senate.gov/api/v1/clients/104656/","client_id":1004710,"name":"EDGE THERAPEUTICS, INC.","general_description":"Biotechnology company","client_government_entity":false,"client_self_select":null,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-05-24"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to PDUFA and the FDA Reauthorization Act of 2017 (H.R. 2430, S. 934).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63646,"prefix":null,"prefix_display":null,"first_name":"EUGENIA","nickname":null,"middle_name":null,"last_name":"PIERSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63611,"prefix":null,"prefix_display":null,"first_name":"KRISTINE","nickname":null,"middle_name":null,"last_name":"BLACKWOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63612,"prefix":null,"prefix_display":null,"first_name":"PARI","nickname":null,"middle_name":null,"last_name":"MODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41525,"prefix":"mr","prefix_display":"MR.","first_name":"DANIEL","nickname":null,"middle_name":"A","last_name":"KRACOV","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}